Allergies
to cow’s milk has become a common ailment among infants, which has
led parents to opt for formula feeding. The U.S. Food and Drug
Administration (FDA) estimates over 1 million infants being fed with
formula instead of breastfeeding in the U.S. currently. The FDA
further foresees over 2.5 million infants to rely on formula until
they are 3 months old. Wide variety of formulas have been developed
for young infants with different tolerance limits, such as soy-based
formulas and amino acid-based formulas.
Although
soy-based formulas might be recommended in light of their lactose
tolerance or cow’s milk protein tolerance, the American Academy of
Pediatrics considers their use for feeding preterm or
low-birth-weight infants unadvisable. Amino acid-based formulas
however are considered to be the first preference in infant formulas,
as they can be fed to new-born as well as young infants intolerant to
casein hydrolysates, soy protein isolates, and cow milk proteins.
Request
to view Sample Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=42251
A
new Transparency Market Research (TMR) report foresees the global
amino acid-based formula market to record an impressive 8.7% value
CAGR through the forecast period, 2017 to 2026. Volume sales of amino
acid-based formula worldwide is pegged to surpass 15,400 tons by
2026-end.
Surging
Incidences of Hypoallergenic Disorders in Infants
Population
across the globe has been witnessing a rise, driven by rising birth
rate in developing nations, coupled with efforts of developed
countries to enhance birth rates. Number of hypoallergenic disorders
in new born and young infants has also been increasing abreast rising
birth rates over the past couple of years. UNICEF and the WHO
estimate over 2-3% of young infants across the globe to be affected
with hypoallergenic disorders, leading them to become intolerant to
cow milk proteins.
This
has further driven demand for effective infant formulas, with amino
acid-based formula being the first preference among parents
worldwide. With several authoritative organizations and governments
around the world taking efforts for improving outcomes of CMPA and
hypoallergenic disorders, demand for amino acid-based formulas will
further gain an uptick in the near future.
Opportunities
exist for Innovation in Flavor & Taste
Most
of the infant formulas based on amino acid have a slightly bitter
taste, with limited flavors. This has further reflected on consumer
hesitation and consumption rejection of infants significantly. Infant
formula manufacturers are therefore developing new formulations to
equip various flavors that would be appealing to infants and
relieving stress off busy parents.
For
example, Neocate Junior, nutritionally complete and powdered
amino-acid based infant formula has been introduced in the market
with various flavors such as strawberry and vanilla. Several other
manufacturers are also focusing on leveraging the opportunity to
develop innovative flavored infant formula products, in order to
increase their market reach.
Over
the years, infant formula manufacturers have made several
improvements in their products, by adding or adjusting ingredients in
response to research developments and trends. Additionally, these
manufacturers adopt attractive packaging solutions such as
ready-to-use plastic bottles having easy-to-grip shapes, for
providing convenience to busy parents in carefully tending to their
children. Key companies contributing to expansion of the amino
acid-based formula market include Ausnutria Dairy Corporation Ltd.,
Abbott Laboratories, Danone, Mead Johnson Nutrition Company, and
Nestlé S.A.
No comments:
Post a Comment